Related Experiment Video
Updated: Aug 8, 2026
In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
The antigen-specific induction of normal human lymphocytes in vitro is down-regulated by a conserved HIV p24 epitope
A L Luzzati1, E Giacomini, L Giordani
1Department of Immunology, Istituto Superiore di Sanità, Rome, Italy.
Insights
Synthetic peptides from human immunodeficiency virus type 1 (HIV-1) core protein p24 inhibit immune responses in vitro. Even short peptides demonstrate dose-dependent inhibition, offering insights into AIDS pathogenesis and potential therapeutic strategies.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) infection leads to immune dysfunction.
- Components of HIV-1 may directly impact immune cell function.
- Understanding HIV-1's immunomodulatory effects is crucial for developing treatments.
Purpose of the Study:
- To investigate the immunoinhibitory effects of synthetic peptides derived from HIV-1 core protein p24.
- To determine the minimal peptide sequence required for inhibiting lymphocyte responses.
- To explore the potential relevance for AIDS pathogenesis and therapeutic development.
Main Methods:
- Synthesis of peptides corresponding to HIV-1 p24 amino acid sequences (218-238) and shorter C-terminal fragments.
- In vitro testing of peptide effects on antigen-dependent peripheral blood lymphocyte (PBL) responses.
- Assessing inhibition of primary antibody response to sheep red blood cells (SRBC) and proliferative response to microbial antigens.
Main Results:
- A 7-amino acid peptide, representing a conserved sequence, significantly inhibited antigen-specific antibody production.
- The same peptide demonstrated dose-dependent inhibition of lymphocyte proliferation to recall antigens.
- These findings confirm immunoinhibitory properties of specific HIV-1 peptide sequences.
Conclusions:
- Specific synthetic peptides from HIV-1 p24 exhibit potent immunoinhibitory activity in vitro.
- Short, conserved peptide sequences are sufficient to impair key immune responses.
- These results contribute to understanding AIDS pathogenesis and may inform immunotherapeutic strategies.
Abstract:
Synthetic peptides containing amino acid sequence 218-238 of the core protein p24 of human immunodeficiency virus type 1 (HIV-1) and progressively shorter sequences at its C-terminus, were tested for their effect on antigen dependent in vitro responses of peripheral blood lymphocytes (PBL) from normal human donors. A peptide as short as 7 amino acids, corresponding to a highly conserved sequence, was able to inhibit in a dose-dependent manner the induction of a specific primary antibody response to the sheep red cell (SRC) antigen, as well as the proliferative response to recall microbial antigens. The results of this study constitute additional evidence of the immunoinhibitory effects of HIV components and may help to unravel some of the pathogenic mechanisms of AIDS. Moreover, they are of potential relevance for the development of immunoprophylactic and therapeutic strategies.
More Related Videos
08:11Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
11:14Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
